FILE:BBT/BBT-8K-20050131162026.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
            On January 25, 2005, upon recommendation by the Nominating and Corporate Governance Committee, BB&T Corporation's ("the Company's") Board of Directors elected John P. Howe, III, M.D. as a director of BB&T Corporation. The Board of Directors determined that Dr. Howe is an independent director, having had no transactions with BB&T that affect his ability to be independent. In addition, Dr. Howe was appointed by the Board of Directors to serve as a member of the Nominating and Corporate Governance and Compensation Committees.
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:       January 31, 2005


